{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,11]],"date-time":"2025-11-11T13:53:19Z","timestamp":1762869199945,"version":"3.37.3"},"reference-count":22,"publisher":"European Respiratory Society (ERS)","issue":"4","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2023,8,21]]},"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1183\/13993003.01387-2023","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T17:40:19Z","timestamp":1697737219000},"page":"2301387","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Charting the path to expanded access for CFTR modulator drugs: the nose knows"],"prefix":"10.1183","volume":"62","author":[{"given":"Christine","family":"Bear","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4057-6592","authenticated-orcid":false,"given":"Felix","family":"Ratjen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"81","published-online":{"date-parts":[[2023,10,19]]},"reference":[{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.1","DOI":"10.1056\/NEJMoa1908639"},{"key":"2024102012361282000_62.4.2301387.2","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1164\/rccm.202108-1986OC","article-title":"Clinical effectiveness of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis: a clinical trial","volume":"205","author":"Nichols","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.3","DOI":"10.1183\/13993003.00110-2023"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.4","DOI":"10.1183\/13993003.02437-2022"},{"key":"2024102012361282000_62.4.2301387.5","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jcf.2022.01.008","article-title":"Forskolin induced swelling (FIS) assay in intestinal organoids to guide eligibility for compassionate use treatment in a CF patient with a rare genotype","volume":"21","author":"Aalbers","year":"2022","journal-title":"J Cyst Fibros"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.6","DOI":"10.1016\/j.celrep.2019.01.068"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.7","DOI":"10.26508\/lsa.202201857"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.8","DOI":"10.1183\/23120541.00448-2020"},{"key":"2024102012361282000_62.4.2301387.9","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.ccm.2022.06.005","article-title":"Novel applications of biomarkers and personalized medicine in cystic fibrosis","volume":"43","author":"Guimbellot","year":"2022","journal-title":"Clin Chest Med"},{"key":"2024102012361282000_62.4.2301387.10","doi-asserted-by":"crossref","first-page":"4448","DOI":"10.3390\/ijms22094448","article-title":"Nasal epithelial cell-based models for individualized study in cystic fibrosis","volume":"22","author":"Keegan","year":"2021","journal-title":"Int J Mol Sci"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.11","DOI":"10.1183\/13993003.02774-2020"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.12","DOI":"10.1183\/13993003.02457-2017"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.13","DOI":"10.1038\/s41598-017-07504-1"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.14","DOI":"10.1183\/13993003.02426-2019"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.15","DOI":"10.1183\/13993003.02379-2018"},{"key":"2024102012361282000_62.4.2301387.16","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1164\/rccm.202110-2249OC","article-title":"Effects of elexacaftor\/tezacaftor\/ivacaftor therapy on CFTR function in patients with cystic fibrosis and one or two F508del alleles","volume":"205","author":"Graeber","year":"2022","journal-title":"Am J Respir Crit Care Med"},{"doi-asserted-by":"crossref","unstructured":"Sadras I , Kerem E , Livnat G , et al. Clinical and functional efficacy of elexacaftor\/tezacaftor\/ivacaftor in people with cystic fibrosis carrying the N1303K mutation. J Cyst Fibros 2023; in press [https:\/\/doi.org\/10.1016\/j.jcf.2023.06.001].","key":"2024102012361282000_62.4.2301387.17","DOI":"10.1016\/j.jcf.2023.06.001"},{"doi-asserted-by":"publisher","key":"2024102012361282000_62.4.2301387.18","DOI":"10.1164\/rccm.201111-2065OC"},{"key":"2024102012361282000_62.4.2301387.19","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.3390\/cells9092137","article-title":"Choice of differentiation media significantly impacts cell lineage and response to CFTR modulators in fully differentiated primary cultures of cystic fibrosis human airway epithelial cells","volume":"9","author":"Saint-Criq","year":"2020","journal-title":"Cells"},{"key":"2024102012361282000_62.4.2301387.20","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.jcf.2019.12.008","article-title":"The influence of CFTR complex alleles on precision therapy of cystic fibrosis","volume":"19","author":"Chevalier","year":"2020","journal-title":"J Cyst Fibros"},{"key":"2024102012361282000_62.4.2301387.21","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.jcf.2022.05.013","article-title":"Severity of the S1251N allele in cystic fibrosis is affected by the presence of the F508C variant in cis","volume":"21","author":"Cuyx","year":"2022","journal-title":"J Cyst Fibros"},{"key":"2024102012361282000_62.4.2301387.22","first-page":"100156","article-title":"High-quality read-based phasing of cystic fibrosis cohort informs genetic understanding of disease modification","volume":"4","author":"Mastromatteo","year":"2023","journal-title":"HGG Adv"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.01387-2023","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T08:14:53Z","timestamp":1740384893000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.01387-2023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":22,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2023,10,19]]},"published-print":{"date-parts":[[2023,10]]}},"alternative-id":["10.1183\/13993003.01387-2023"],"URL":"https:\/\/doi.org\/10.1183\/13993003.01387-2023","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"type":"print","value":"0903-1936"},{"type":"electronic","value":"1399-3003"}],"subject":[],"published":{"date-parts":[[2023,10]]}}}